| Zhuang Research Lab | ||
|
Cellular entry of viruses and non-viral gene delivery vectors
1. Visualizing individual influenza virus particles in living cells (past achievement) 2. Entry mechanisms of influenza viruses (past achievement and current project) 3. Endocytic trafficking of influenza viruses (past achievement and current project) 4. Nuclear import of influenza genome (past achievement) 5. Entry mechanism(s) of polioviruses (current project) 6. Entry mechanism(s) of polyomaviruses (current project) 7. Cellular entry and trafficking of polymeric gene-delivery vectors (current project) 1. Visualizing individual influenza virus particles in living cells (past achievement) Each year, 10-20% of U.S. residents are infected by influenza; among these, about 36,000 people die of flu-related complications. This reminds us of one of the biggest human tragedies of all time - the notorious 1918 flu pandemic that claimed the lives of 20 million people worldwide. The exact reason why the 1918 influenza virus was so dangerous and virulent is still unknown. It may be just a matter of time before another strain of influenza virus emerges with a similar devastating power. The situation clearly demands an improved understanding of infection mechanisms of influenza viruses, to provide new insights of the disease and to suggest new strategies for treatment. Our research currently focuses on the type A influenza virus, an enveloped virus with a lipid-bilayer membrane, a protein matrix, and a segmented genome, comprised of eight single-stranded RNAs packed into ribonucleoprotein (vRNP) complexes. A scheme of influenza A is shown is Fig. 1. Influenza viruses infect cells via receptor-mediated endocytosis, followed endocytic trafficking of influenza to acidic endosomes, and fusion of the viral membrane with endosomes to deliver the viral genome (vRNPs) into the cell. The vRNPs are then imported to the nucleus to initiate viral gene expression and replication . Despite intensive studies of influenza infection, many important aspects of cellular entry process of influenza still remain elusive.
We have developed imaging methods to visualize single influenza virus particles inside living cells. By tracking individual viruses in real time using advanced fluorescence microscopy, we have monitored the transport, acidification and fusion of influenza viruses in living cells (Fig. 2, movies 1 and 2 ). Our single-virus trajectories directly reveal a three-stage active-transport behavior of the viruses preceding viral fusion, each stage having a distinct molecular mechanism (Fig. 3, movie 1). Stage I is an actin-dependent movement in the cell periphery, primarily on the cell surface. Stage II is a rapid, dynein-directed translocation on the microtubule that delivers the virus from cell periphery to the perinuclear region. Stage III depicts an intermittent movement involving both plus- and minus-end-directed microtubule-based motilities in the perinuclear region. By monitoring the local chemical environment of individual viruses, including the pH level and the protein content of the endocytic compartment containing the virus, we have discovered new trafficking and sorting mechanisms for viruses inside the cell's endocytic network (Fig. 3, Movie 2 ).
Reference:
2. Entry mechanisms of influenza viruses (past achievement and current project) While many viruses are known to infect cells via receptor-mediated endocytosis, the exact endocytic mechanisms have remained unclear for most of them. Due to the presence of multiple endocytic pathways in cells, including phagocytosis, macropinocytosis, clathrin-mediated endocytosis, caveolin-mediated endocytosis, and clathrin- and caveolae-independent pathways, determining the exact endocytic mechanisms used by viruses has been challenging . By tracking the interaction of single influenza viruses with cellular endocytic structures using real-time fluorescence microscopy, we observed individual viral entry events directly, isolated those entry events that led to viral fusion - an obligatory step for infection, and characterized the endocytic mechanism underlying each event. Using this approach, we have shown that influenza can exploit clathrin-mediated and clathrin/caveolin-independent pathways in parallel, both pathways leading to viral fusion (Figs. 4 & 5, Movies 3 , 4 , & 5 ). These experiments allowed us to quantitatively determine the partition of the viruses among different endocytic pathways. . We have also addressed another important question: How are viruses targeted to cellular endocytic structures for entry? We observed a novel phenomenon: those influenza viruses using the clathrin pathway enter cells predominantly via the de novo formation of clathrin-coated pits (CCPs) at the viral binding sites (Movies 3 and 4). Remarkably, CCP formation at these sites is much faster than elsewhere on the cell surface. The kinetics and spatial distribution of the CCP formation suggest that these CCPs are most likely induced by viral binding. Considering the lack of specific influenza receptors with internalization motifs, we suggest a potentially general mechanism to promote CCP formation, and thereby viral entry, that may be used by many virus types: The multivalent binding of the virus to cells induce local curvature on the plasma membrane, which can be detected by curvature-sensing components of CCPs, thereby promoting formation of a CCP. Currently, we are testing this hypothesis by monitoring CCP formation around objects with various radii of curvature, by perturbing the curvature-sensing capability of CCP components, and by monitoring different components of the CCPs forming at the sites of bound viruses in real time. These experiments will elucidate the mechanism(s) that influenza exploit to induce CCP formation.
Reference:
3. Endocytic trafficking of influenza viruses (past achievement and current project) Influenza viruses are believed to fuse their envelope with acidic endosomes to release their genome into the cell. It is therefore of great interest to understand how influenza viruses are trafficked toward those endosomes. The dynamic nature of the endocytic network makes it highly desirable to address this question by real-time imaging. By tracking single viruses simultaneously with different types of endosomes specifically labeled with fluorescent endocytic markers or Rab GTPases, we observed that influenza viruses are sorted to a small sub-population of endosomes that are highly dynamic and rapidly maturing. By largely avoiding the other relatively static "early" endosomes, these viruses put themselves in a position to quickly achieve fusion. How such a "smart" choice is made is currently under investigation. 4. Nuclear import of influenza genome (past achievement) The influenza genome is comprised of eight single-stranded RNAs packed into ribonucleoprotein (vRNP) complexes. After the vRNPs are released into the cell by viral fusion, they need to be imported to the nucleus for viral gene expression and replication . We have extended the single-particle tracking technique to investigate the nuclear trafficking of the viral genome. By directly tracking individual vRNP particles in live cells (Movie 6), we have determined the transport mechanisms of vRNPs in cells - vRNP particles diffuse rapidly both inside the cytoplasm and inside the nucleus without exhibiting directed movement (Fig. 6). We have observed heterogeneous interactions between the vRNPs and nuclear pore complexes (NPCs) with dissociation rate constants spanning two orders of magnitude.
The nuclear import of the influenza vRNPs are regulated, a property that is critical for the replication of the influenza viruses. While it is known that the influenza matrix protein, M1, is responsible for down-regulating the nuclear-import of vRNP, how M1 achieves this goal has remained elusive. Our single-particle tracking experiments have provided new insights into the regulation mechanism - M1, down-regulates the nuclear-import of vRNP by inhibiting the interaction of vRNPs with the nuclear pore complexes, but not by inhibiting the transport of vRNPs (Fig. 7).
Reference: 5. Entry mechanisms of polioviruses (current project)
We have recently developed a fluorescent labeling method that does not perturb the infectivity of poliovirus, but allow individual polioviruses to be visualized in living cells and the release of a single polio genome to be observed in real time. We are currently investigating the polio entry mechanism by tracking the behavior of individual poliovirus particles in living cells and by tracking the interaction of polioviruses with relevant cellular machinery potentially responsible for the viral entry. We shall complement these real-time imaging studies with conventional infectivity tests and structural analysis of polioviruses.
6. Exploring the entry mechanisms of polyomaviruses (current project)
Using the single particle-tracking method that we have developed for investigating influenza and polio viral entry, we are currently investigating the cellular entry mechanism of human polyomaviruses, BKV and JCV, and comparing their entry behavior with that of the relatively well studies SV40 viruses.
7. Cellular entry and trafficking of polymeric gene-delivery vectors (current project) Gene delivery refers to the introduction of exogenous DNA into a host cell for the production of an absent or defective protein. It has emerged as a promising therapeutic method for a variety of diseases including cystic fibrosis, Parkinson's disease, and certain cancers. Using similar vector technology, small interfering RNA (siRNA) provides a possibility of RNA-based therapeutics. Exciting results have shown that siRNA has therapeutic potential for diseases ranging from influenza to Huntington 's. For both DNA and siRNA, the most important component of a delivery system is the vector, which assists the entry of DNA or siRNA into the cell and prevents their degradation. While viruses are the most efficient gene-delivery vectors, it is becoming increasingly clear that non-viral vectors may prove to be a safer, more easily controlled method of gene delivery. Polymer-mediated gene delivery replaces the conventional viral vector with a positively charged polymer. This cationic polymer binds to the anionic DNA or siRNA, causing it to condense into a small complex with a net positive charge. At present, the best polymeric gene-delivery vectors is still a few orders of magnitude less efficient than viral vectors. A detailed understanding of the entry and trafficking mechanisms of polymer-DNA complexes is critical for the rational design of polymer vectors with much improved efficiency. Using a combination of fluorescence microscopy, single-particle tracking, and drug inhibition we have characterized the endocytic pathway of polymer-mediated gene delivery using the cationic polymer vector, polyethylenimine (PEI). These techniques provide a real-time, dynamic picture of polymer-mediated gene delivery in live cells, allowing us to observe the individual steps on the gene delivery pathway and to directly assess the efficiency of each step. Our results indicate that PEI-DNA complexes are internalized and trafficked in cells via a novel, previously uncharacterized endocytic pathway, providing new insights into the barriers for polymer-mediated gene delivery. Currently, we are extending our investigation into several newly developed gene-delivery polymers synthesized by our collaborators' laboratories, assessing their performance on each steps of the gene-delivery pathway to provide further insights for rational designs of polymers with improved gene delivery efficiency.
Our collaborators on the poliovirus and gene-delivery projects: Links to our other research areas: |